Interim Analysis Results of a Phase 2 Trial of Low-Dose Radiation Therapy for Palliation of Diffuse Large B-Cell Lymphoma

被引:0
|
作者
Furlan, C. [1 ]
Bulian, P. [1 ]
Spina, M. [1 ]
Michieli, M. [1 ]
Ermacora, A. [2 ]
Tirelli, U. [1 ]
Trovo, M. [1 ]
机构
[1] CRO Aviano Natl Canc Inst, Aviano, Italy
[2] Osped Santa Maria degli Angeli, Pordenone, Italy
关键词
D O I
10.1016/j.ijrobp.2014.05.463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
171
引用
收藏
页码:S80 / S80
页数:1
相关论文
共 50 条
  • [41] GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS
    Schuster, S. J.
    Bishop, M. R.
    Tam, C.
    Waller, E. K.
    Borchmann, P.
    McGuirk, J.
    Jaeger, U.
    Jaglowski, S.
    Andreadis, C.
    Westin, J.
    Fleury, I.
    Bachanova, V.
    Foley, S. R.
    Ho, P. J.
    Mielke, S.
    Magenau, J. M.
    Holte, H.
    Anak, O.
    Pacaud, L.
    Awasthi, R.
    Tai, F.
    Salles, G.
    Maziarz, R. T.
    HAEMATOLOGICA, 2017, 102
  • [42] Validation of the DSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
    Itti, Emmanuel
    Blanc-Durand, Paul
    Berriolo-Riedinger, Alina
    Kanoun, Salim
    Kraeber-Bodere, Francoise
    Meignan, Michel
    Gat, Elodie
    Le Gouill, Steven
    Casasnovas, Rene-Olivier
    Bodet-Milin, Caroline
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1706 - 1711
  • [43] Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma
    Baron, Jonathan A.
    Wright, Christopher M.
    Dreyfuss, Alexandra D.
    Chong, Elise A.
    Svoboda, Jakub
    LaRiviere, Michael J.
    Jones, Joshua A.
    Maity, Amit
    Plastaras, John P.
    Paydar, Ima
    Maxwell, Russell
    PRACTICAL RADIATION ONCOLOGY, 2024, 14 (05) : e362 - e372
  • [44] The impact of chemoimmunotherapy dose intensity in diffuse large b-cell lymphoma
    Chu, Michael P.
    Ghosh, Sunita
    Belch, Andrew
    Chua, Neil S.
    Fontaine, Amelie
    Sangha, Randeep
    Turner, Robert
    Venner, Christopher
    Baracos, Vickie
    Sawyer, Michael B.
    CANCER RESEARCH, 2015, 75
  • [45] Final results of a phase II trial of R-IDEA as salvage therapy in patients with relapsed/refractory diffuse large B-cell lymphoma
    Kondo, E.
    Yamamoto, K.
    Masunari, T.
    Takizawa, J.
    Miura, K.
    Masaki, Y.
    Matsumura, T.
    Hiramatsu, Y.
    Murakam, J.
    Tsujimura, H.
    Tomita, N.
    Maeda, Y.
    Kanno, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial
    LaRiviere, Michael J.
    Vaziri, Tina
    Farwell, Michael
    Maity, Amit
    Paydar, Ima
    Schuster, Stephen J.
    Nasta, Sunita Dwivedy
    Chong, Elise A.
    Landsburg, Daniel J.
    Plastaras, John P.
    Svoboda, Jakub
    BLOOD, 2022, 140 : 3726 - 3727
  • [47] Clinical Outcomes for Patients with Diffuse Large B-cell Lymphoma Treated with Radiation Therapy and Lenalidomide
    Kim, Sungjune
    Shah, Shreni
    Yu, Su-Yuan
    Mills, Matthew
    Figura, Nicholas
    Robinson, Timothy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S112 - S112
  • [48] Radiation Therapy Improves Outcomes in Patients With Primary Testicular Diffuse Large B-cell Lymphoma
    Ho, J. C.
    Reddy, J.
    Mazloom, A.
    Allen, P. K.
    Milgrom, S. A.
    Smith, G. L.
    Medeiros, L. J.
    Young, K. H.
    Fowler, N. H.
    Dabaja, B.
    Pinnix, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S20 - S20
  • [49] Valproate in Combination with Rituximab and CHOP As First Line Therapy in Diffuse Large B-Cell Lymphoma (VALFRID): Preliminary Results from a Phase I Trial with a Dose Expansion Cohort
    Drott, Kristina
    Hagberg, Hans
    Relander, Thomas
    Graffman, Cecilia
    Drott, Johan
    Jerkeman, Mats
    BLOOD, 2015, 126 (23)
  • [50] Metformin in Combination With the Standard Therapy in Patients With Diffuse Large B-Cell Lymphoma: A Randomized Phase II Clinical Trial
    Alagizy, Hagar
    Mubarak, Nabil
    Hegazy, Amira
    Sohaib, Ahmed
    Ali, Manar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S415 - S415